BrainsWay Ltd. (BWAY) Comparison with companies in other sectors?

BrainsWay Ltd. has a share price of 18.90M. You can analyze BrainsWay Ltd. (BWAY) competitors across different market sectors through stock heatmaps.

What are BWAY's NET and operating margins?

BrainsWay Ltd. (BWAY) operating margin is around 0.04, and net profit margin is approximately 0.09 as of the latest reports.

In what way does BWAY's earnings per share (EPS) trend reflect its financial momentum?

BrainsWay Ltd. (BWAY) EPS is 0.22 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for BrainsWay Ltd. is 53.32, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for BrainsWay Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for BrainsWay Ltd. like P/E which is 55.27, P/B which is 3.40, and PEG which is 1.84. Compare them with sector averages to evaluate if the stock is priced fairly.

BrainsWay Ltd.

BWAY•NASDAQ

Healthcare

Medical - Devices

$11.73

$-0.11(-0.93%)

Fundamental Analysis of BrainsWay Ltd. (BWAY)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.22

P/E Ratio

53.32

ROE

0.07%

Net Margin

0.09%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$221.67M

Shares OutstandingTotal number of shares issued

$18.90M

Book Value/ShareNet worth per share

$3.46

Revenue/ShareAnnual revenue per share

$2.36

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.22

Net MarginNet income as percentage of revenue

9.01%

Operating MarginOperating income as percentage of revenue

4.31%

ROEReturn on shareholders' equity

7.35%

ROAReturn on total assets

3.91%

ROCEReturn on capital employed

2.25%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.43

Cash/ShareCash and equivalents per share

$3.88

FCF YieldFree cash flow as percentage of market cap

3.63%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for BWAYFinancial Ratios Analysis details for BWAY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for BWAYSector Benchmarking details for BWAY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for BrainsWay Ltd. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of BrainsWay Ltd.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account BrainsWay Ltd.'s unique business strengths and challenges.

Key Financial Metrics for BrainsWay Ltd.

For BrainsWay Ltd., essential financial indicators include EPS 0.22, PE 53.32, and ROE 0.07. These key ratios reveal insights into BrainsWay Ltd.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare BrainsWay Ltd. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of BrainsWay Ltd.

Metrics like Net Margin 9.01% and ROA 3.91% shed light on how well BrainsWay Ltd. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether BrainsWay Ltd. can sustain its operations and continue growing in the future.

Valuation and Market Position of BrainsWay Ltd.

Using ratios such as P/B Ratio 3.40 and PEG Ratio 1.84, investors can assess whether BrainsWay Ltd. is appropriately valued based on its financials and growth potential. These figures, combined with BrainsWay Ltd.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for BrainsWay Ltd.

Financial health indicators, such as Debt/Equity Ratio 0.09 and Cash Flow $0.43, provide a snapshot of BrainsWay Ltd.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like BrainsWay Ltd., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for BrainsWay Ltd.

Investing in BrainsWay Ltd. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at BrainsWay Ltd. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;